SynBioBeta Speaker

Aryé Elfenbein

Wildtype

Co-founder

Aryé co-founded Wildtype, a company creating a clean, accessible seafood future using cellular agriculture technologies. Wildtype has developed brewery-like systems to grow seafood directly from cells, without the need for fishing or farming. After regulatory clearance in the US, Wildtype became the first company in the world to commercialize a cultivated seafood, starting with salmon. Aryé earned his MD and PhD at Dartmouth and Kyoto University; he completed clinical training in Internal Medicine and Cardiology at Yale. Prior to co-founding Wildtype, Aryé completed a fellowship in cardiovascular regenerative medicine at The Gladstone Institutes / UCSF. A classically-trained cardiologist and musician, Aryé often spends nights practicing in the ICU and piano room.

Sessions Featuring

Aryé

This Year

Breakout Session

•

4:30 PM

-

5:15 PM

Planetary Health

From Feedstock to Fork: De-Risking Bio-Based Foods at Industrial Scale

Bio-based food innovation rarely fails in the lab. It fails in the transition to scale. Between pilot success and commercial launch lie the hardest problems in food: reliable feedstocks, waste stream integration, regulatory approval, capital intensity, and infrastructure built for yesterday’s products. This session brings together leaders across law, industrial food systems, waste valorization, and next-generation proteins to examine what it actually takes to move biological food innovations from concept to shelf. Panelists will explore where risk truly accumulates in bio-based food development, how incumbents and startups navigate scale differently, and why waste streams, compliance strategy, and supply chain design often matter more than the underlying biology. The result is a grounded conversation about what survives real-world constraints, not just what sounds compelling on paper.

Featuring

Michael Gay

Univ. of Wisconsin CDR

Tech Transfer/Bus Dev

Aryé Elfenbein

Wildtype

Co-founder

Cardiologist turned cultivated-seafood pioneer reinventing how we eat fish.

Robert-Jan de Voogd

Corbion

General Manager

Celine Schiff-Deb

MISTA | Givaudan

CSO

Food-biotech translator: microalgae oils and methane-to-protein scaleups.

Lauren Greenlee

XPRIZE

EVP

Breakout Session

•

4:30 PM

-

5:15 PM

Planetary Health

From Feedstock to Fork: De-Risking Bio-Based Foods at Industrial Scale

Bio-based food innovation rarely fails in the lab. It fails in the transition to scale. Between pilot success and commercial launch lie the hardest problems in food: reliable feedstocks, waste stream integration, regulatory approval, capital intensity, and infrastructure built for yesterday’s products. This session brings together leaders across law, industrial food systems, waste valorization, and next-generation proteins to examine what it actually takes to move biological food innovations from concept to shelf. Panelists will explore where risk truly accumulates in bio-based food development, how incumbents and startups navigate scale differently, and why waste streams, compliance strategy, and supply chain design often matter more than the underlying biology. The result is a grounded conversation about what survives real-world constraints, not just what sounds compelling on paper.

Featuring

Michael Gay

Univ. of Wisconsin CDR

Tech Transfer/Bus Dev

Aryé Elfenbein

Wildtype

Co-founder

Cardiologist turned cultivated-seafood pioneer reinventing how we eat fish.

Robert-Jan de Voogd

Corbion

General Manager

Celine Schiff-Deb

MISTA | Givaudan

CSO

Food-biotech translator: microalgae oils and methane-to-protein scaleups.

Lauren Greenlee

XPRIZE

EVP

Previous Speakers Include